I would have thought that uni was an attractive takeover before yesterdays announcement. Forgetting the dull response from Aussie investors surely existing syringe manufacturers can see the emerging threat Uni provides to their bottom line. I personally would not like to see some new kid on the block stealing away any market share I was enjoying. Maybe Mr. Bot has something to do with this scenario??
